Progress of molecular epidemiology of mycoplasma pneumoniae in children / 国际儿科学杂志
International Journal of Pediatrics
; (6): 488-491, 2021.
Article
in Zh
| WPRIM
| ID: wpr-907264
Responsible library:
WPRO
ABSTRACT
Mycoplasma pneumoniae(MP)is the main pathogen causing community-acquired pneumonia in children, usually treated with macrolide drugs.The type of MP genes is mainly based on PCR-RFLP(P1-restriction fragment length polymorphism analysis)and MLVA(multiple locus variable number tandem repeat analysis)typing methods.During epidemics, MP subtypes will undergo certain transformation.Studying and mastering the prevalence characteristics and transformation laws of MP subtypes can deeper understand the distribution area, prevalence year and clinical relevance of each subtype of MP.Due to the extensive use of antibiotics, the resistance of mycoplasma pneumoniae to macrolides has increased , which has become a global public health concern.Studies have shown that MP resistance is related to mutations in the V region of 23S rRNA gene domain.The improvement of typing technology also guides significance for the rational selection of antibiotics.It is imperative to carry out systematic and comprehensive molecular epidemiological studies of MP genotypes and its resistance mutations, and reveal the distribution characteristics, epidemic trends and resistance mutations of MP subtypes at the molecular level.This paper reviews the research progress of molecular epidemiology of mycoplasma pneumoniae in children, and provides ideas for the monitoring, prevention and clinical treatment of MP infection.
Full text:
1
Index:
WPRIM
Type of study:
Screening_studies
Language:
Zh
Journal:
International Journal of Pediatrics
Year:
2021
Type:
Article